ACR20 Pearls Part 3: Pragmatic Applications for Managing Vasculitis
Feb 11, 2020
Blogs
While the ACR prepares to publish its new guidelines for the diagnosis and management of vasculitis in the Spring of 2020, Dr. John Stone presented his own perspectives on the practical management of vasculitis during the 2019 ACR meeting in Atlanta. He acknowledged that what may be pearls one day, may be disproven with data in the future.
The IL-6 Wars
Jan 10, 2017
In the years to come, the availability of numerous new IL-6 inhibitors it will either complicate treatment decisions, alter existing treatment paradigms, or result in an all-out war against TNF inhibitor dominance. Data, differences and time will tell.
Cannabis Arteritis
Dec 01, 2016
KOLs Predict: What Will the Next Year Bring?
Apr 27, 2016
A new subspecialty may emerge. New drugs will be approved (but it will be difficult for patients to get coverage for them). And an American team will win the World Series. All these and more: here are predictions for 2017 and beyond from rheumatologists across the country and around the world.
A Winning Season*
Sep 09, 2015
Winning is everything – in football and in medicine. Rheumatologists have achieved many successes but still struggle to win against a handful of rheumatic foes. This retrospective examines past wins and losses and helps us to look ahead to a new season.
Hot Stuff Part IV: Cardiovascular Outcomes and Vasculitis
May 08, 2015
The last in a four-part series from the CCF's Biologic Therapies Summit, we examine how to reduce CV risks in practice plus the current status of vasulitis management and the role biologics may play.